Physician profile
William Clay Jackson
NPI 1407858368
$93,274.82
in general payments reported to CMS, 2019-2025
17 companies · $1,541 in 2025
The $1,541 reported for 2025 was more than what 97% of Hospice and Palliative Medicine (Family Medicine) providers received nationally (typical 2025 total: $78.57).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39K · 2020: $2,276 · 2021: $7,706 · 2022: $28K · 2023: $7,446 · 2024: $7,880 · 2025: $1,541.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Food and Beverage: $918 · Travel and Lodging: $788.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,160.00 |
| Food and Beverage | $918.26 |
| Travel and Lodging | $788.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, INC. | $26,827.88 | 2019-2024 | Rexulti |
| Otsuka America Pharmaceutical, INC. | $20,687.34 | 2019-2023 | |
| Genentech USA, INC. | $15,460.90 | 2019-2022 | |
| H. Lundbeck A S | $8,074.09 | 2019-2021 | |
| Pfizer INC. | $7,194.73 | 2019 | |
| Sunovion Pharmaceuticals INC. | $4,391.97 | 2019 | |
| Biogen, INC. | $3,132.00 | 2022 | |
| Allergan, INC. | $2,549.23 | 2020-2022 | |
| Janssen Scientific Affairs, LLC | $1,450.00 | 2024 | |
| Alkermes, INC. | $1,087.45 | 2021-2024 | Lybalvi |
| Abbvie INC. | $823.31 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $817.50 | 2025 | |
| Merz North America, INC. | $589.97 | 2022-2023 | Xeomin |
| Bayer Healthcare Pharmaceuticals INC. | $117.47 | 2023 | |
| Neurocrine Biosciences, INC. | $29.12 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $26.08 | 2019 | |
| Genzyme Corporation | $15.78 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.